Sangamo Therapeutics (SGMOQ) Minority Interest (2018 - 2021)

Sangamo Therapeutics has reported Minority Interest for 4 years, with the latest figure at -$938000.0 in Q1 2021.

• On a quarterly basis, Minority Interest fell 856.45% year-over-year to -$938000.0 in Q1 2021; TTM through Mar 2021 was -$938000.0, a 856.45% decrease from a year earlier, with the FY2020 full-year figure at -$868000.0, down 569.19% from the prior year.
• Minority Interest was -$938000.0 for Q1 2021 at Sangamo Therapeutics, down from -$868000.0 in the prior quarter.
• The five-year high for Minority Interest was $739000.0 in Q4 2018, with the low at -$938000.0 in Q1 2021.
• Average Minority Interest over 4 years is $0.0, with a median of $154500.0 recorded in 2019.
• The sharpest annual moves came in 2019 and 2021: Minority Interest plunged 74.97% in 2019, then tumbled 856.45% in 2021.
• Over 4 years, Minority Interest stood at $739000.0 in 2018, then slumped by 74.97% to $185000.0 in 2019, then sank by 569.19% to -$868000.0 in 2020, then dropped by 8.06% to -$938000.0 in 2021.
• The last three Minority Interest figures came in at -$938000.0 (Q1 2021), -$868000.0 (Q4 2020), and -$530000.0 (Q3 2020), per Business Quant data.